CASI Pharmaceuticals, Inc. — Investor Relations & Filings
CASI Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for organ transplantation and autoimmune diseases. The company's lead program is centered on CID-103, an investigational anti-CD38 monoclonal antibody. This therapy is being developed to address antibody-mediated rejection (AMR) in organ transplant recipients, a significant unmet medical need with no currently approved treatments. The mechanism of CID-103 targets B memory cells, plasmablasts, and persistent plasma cells that can contribute to organ rejection. The company is also exploring the potential of this anti-CD38 approach for treating various autoimmune diseases, such as immune thrombocytopenia (ITP).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 20-F | 2026-05-15 | English | |
| 6-K - CASI Pharmaceuticals, Inc. (0001962738) (Filer) | 2026-04-20 | English | |
| 6-K - CASI Pharmaceuticals, Inc. (0001962738) (Filer) | 2026-04-15 | English | |
| 3 - CASI Pharmaceuticals, Inc. (0001962738) (Issuer) | 2026-03-27 | English | |
| 3 - CASI Pharmaceuticals, Inc. (0001962738) (Issuer) | 2026-03-25 | English | |
| SCHEDULE 13D/A - CASI Pharmaceuticals, Inc. (0001962738) (Subject) | 2026-03-23 | English |
Browse filings by year
4 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
CASI Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34962/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34962 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34962 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34962 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34962}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CASI Pharmaceuticals, Inc. (id: 34962)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.